Core Points - The Evry Commercial Court rejected both final takeover bids for Global Bioenergies due to insufficient employee retention in the first bid and failure to meet satisfactory takeover conditions in the second bid [1] - Following the court's decision, the receivership procedure was converted into judicial liquidation, and a liquidator was appointed to sell the company's assets, particularly its patent portfolio [2] - Global Bioenergies has requested to delist its shares from Euronext Growth, which will render them worthless for shareholders [2]

Core Points - The review hearing for the takeover offers of Global Bioenergies has been postponed to 24 November 2025, with a new deadline for submitting offers set for 12 November 2025 [2] - The company initiated a pre-pack sale process on 3 June 2025, and a receivership procedure was opened by the Evry Commercial Court on 29 September 2025 to implement a sale plan [2] - If no final offer is made, judicial liquidation proceedings will commence simultaneously with the court's judgment, likely resulting in the delisting of Global Bioenergies' shares, with residual value expected to be zero due to liabilities exceeding asset sale proceeds [3] - The company is currently unable to finalize its half-year financial statements due to uncertainties surrounding the ongoing process [4]

Core Viewpoint - Global Bioenergies has entered a receivership procedure aimed at evaluating and implementing solutions to continue operations and maintain jobs, primarily through a sale plan [2][4]. Group 1: Receivership Procedure - The Evry Commercial Court has appointed SCP Abitbol & Rousselet as the administrator for Global Bioenergies [2]. - This procedure follows a pre-pack sale process initiated on June 3, 2025 [2]. - Four offers to take over part of the assets have been submitted to the court, with the possibility of changes and conditions that need to be met before the review hearing [3]. Group 2: Potential Outcomes - If certain assets or activities are taken over, or if no final offer is made, judicial liquidation proceedings will commence [4]. - The judicial liquidation is expected to lead to the delisting of Global Bioenergies' shares, with a likely residual value of zero due to anticipated asset sale proceeds being lower than liabilities [5]. - A hearing to review the takeover offers is scheduled for November 3, 2025 [5]. Group 3: Company Background - Global Bioenergies focuses on producing sustainable aviation fuel (SAF) and e-SAF from renewable resources, contributing to the decarbonization of air transport [6]. - The company's technology is certified by ASTM and meets high standards in the cosmetics industry, with L'Oréal being the largest shareholder at 13.5% [6]. - Global Bioenergies is listed on Euronext Growth in Paris under the code FR0011052257 - ALGBE [6].

Group 1 - The company Global Bioenergies has received four preliminary offers for the takeover of some activities and assets as part of a pre-pack sale process initiated on June 3, 2025 [3][4]. - No proposals have been submitted for the takeover of shares, which will become worthless upon the company's liquidation following the potential asset sale [4][5]. - The offers are still in a preliminary stage and may change, with conditions that must be met before the review hearing, which is expected to occur in September or October 2025 [5]. Group 2 - Global Bioenergies is focused on combating global warming by developing a unique process to produce sustainable aviation fuel (SAF) and e-SAF from renewable resources, addressing the decarbonization of air transport [6]. - The company's technology is one of the few certified by ASTM, and its products also meet high standards in the cosmetics industry, with L'Oréal being the largest shareholder, holding a 13.5% stake [6].

Core Points - The deadline for potential buyers to submit preliminary bids for Global Bioenergies has been extended to 18 July 2025, allowing more time for interested parties to conduct their studies [2] - Two offers and three letters of intent have been received, indicating interest in the company's assets [2] - A review hearing for final offers is expected to take place in September or October [3] Company Situation - Global Bioenergies is undergoing a pre-pack sale process aimed at maintaining business activities and jobs, but shareholders will not receive compensation, leading to a total loss of their investments [5] - The company has significant debts amounting to €13 million, which has hindered its ability to finance future operations as a listed entity [5] - Despite a promising partnership project with an undisclosed major industrialist, the company was unable to bring its solution to the Sustainable Aviation Fuel (SAF) market [5] Technology and Market Position - Global Bioenergies has developed a unique process for producing SAF and e-SAF from renewable resources, contributing to the decarbonization of air transport [6] - The company's technology is one of the few certified by ASTM, and its products meet high standards in the cosmetics industry, with L'Oréal being the largest shareholder at 13.5% [6]

Core Viewpoint - Global Bioenergies is officially seeking buyers due to an inability to secure strategic investors to continue its operations, leading to a pre-pack sale process as part of a conciliation procedure [2][4][6]. Financial Position - The company currently has a gross cash position of 3.0 million euros and carries a bank debt of 13.1 million euros as of December 31, 2024, which remains fully on the balance sheet due to deferred repayments [3]. - The proceeds from the anticipated sale are unlikely to cover shareholder losses, indicating a total loss for existing shareholders [7]. Business Strategy and Challenges - The company shifted its focus to an R&D collaboration project with a major international industrial player to develop sustainable aviation fuels after failing to finance its first plant project [5]. - Despite engaging with numerous potential investors, no interest has been shown in acquiring a stake in the company, attributed to the current geopolitical climate and adverse investment conditions for climate solutions [6]. Sale Process - The pre-pack sale process allows potential buyers to acquire all or part of the company's business and assets, with a deadline for offers set for July 9, 2025 [4][8]. - The Commercial Court of Evry will evaluate the offers, with a potential closing of the sale expected in September or October 2025 [8]. Company Overview - Global Bioenergies specializes in producing sustainable aviation fuels (SAF) and e-SAF from renewable resources, contributing to the decarbonization of air transport [9]. - The company is listed on Euronext Growth in Paris, with L'Oréal as its largest shareholder, holding a 13.5% stake [9].

Company Overview - Global Bioenergies is focused on combating global warming by developing a unique process to produce Sustainable Aviation Fuel (SAF) and e-SAF from renewable resources, addressing the decarbonization challenges in air transport [3] - The company's technology is one of the few solutions certified by ASTM, ensuring compliance with industry standards [3] - L'Oréal is the largest shareholder of Global Bioenergies, holding a 13.5% stake in the company [3] Recent Developments - The term of office for Mrs. Corinne Granger, Chairwoman of the Board of Directors, has expired, and her renewal was not put to a shareholder vote [2] - Mr. Marc Delcourt, who is also the Chief Executive Officer, has been appointed as the new Chairman of the Board of Directors following the Annual General Meeting [2]